Efficacy and safety of dovitinib in pretreated advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase II study

被引：2

作者：

Ahn, Myung-Ju ^{[1
]}

Lim, Sung Hee ^{[1
]}

Sun, Jong -Mu ^{[1
]}

Choi, Yoon-La ^{[1
]}

Kim, Hye Ryun ^{[2
]}

Ahn, Soo-min ^{[1
]}

Lee, Se-Hoon ^{[1
]}

Ahn, Jin Seok ^{[1
]}

Park, Keunchil ^{[1
]}

Kim, Joo Hang ^{[2
]}

Cho, Byoung Chul ^{[2
]}

机构：

[1] Samsung Med Ctr, Seoul, South Korea

[2] Yunsei Univ, Seoul, South Korea

来源：

JOURNAL OF THORACIC ONCOLOGY | 2016年 / 11卷 / 02期

关键词：

D O I：

10.1016/j.jtho.2015.12.027

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S16 / S16

页数：1

共 50 条

[31] Efficacy and safety of iruplinalkib (WX-0593) in ALK-positive crizotinib-resistant advanced non-small cell lung cancer patients: a single-arm, multicenter phase II study (INTELLECT) [J].

Shi, Yuankai ;

Chen, Jianhua ;

Zhang, Helong ;

Zhang, Zhihong ;

Zhang, Yiping ;

Wang, Zhehai ;

Zhang, Shucai ;

Zhao, Jian ;

Liu, Chunling ;

Wang, Xiuwen ;

Zhao, Yanqiu ;

Hu, Changlu ;

Yang, Lei ;

Hao, Xuezhi ;

Wang, Lin ;

Liu, Yunpeng ;

Yu, Yan ;

Zhao, Jun ;

Wang, Mengzhao ;

Zhang, Liangming ;

Sun, Sanyuan ;

Hu, Yanping ;

Gu, Kangsheng ;

Hang, Xiaosheng ;

Shan, Jinlu ;

Zhang, Yu ;

Tan, Bangxian ;

Yang, Weihua ;

Yang, Runxiang ;

Si, Meimei ;

Geng, Huaize ;

Li, Hui ;

Kang, Xiaoyan .

BMC MEDICINE, 2023, 21 (01)

[32] The efficacy and safety of chemo-free therapy in epidermal growth factor receptor tyrosine kinase inhibitor-resistant advanced non-small cell lung cancer: A single-arm, phase II study [J].

Zhang, Shuyang ;

Yang, Lu ;

Yang, Yaning ;

Yang, Guangjian ;

Xu, Haiyan ;

Niu, Xueliang ;

Wang, Yan .

CANCER MEDICINE, 2023, 12 (19) :19438-19448

[33] Efficacy and safety of ensartinib in ALK-positive non-small cell lung cancer patients with brain metastases: A multicenter, open-label, single-arm, phase II study [J].

Chang, J. ;

Wu, X. ;

Guo, L. ;

Zhang, T. ;

Fu, C. ;

Huang, S. ;

Jiang, G. .

ANNALS OF ONCOLOGY, 2023, 34

[34] Perioperative serplulimab and chemotherapy in patients with resectable squamous non-small cell lung cancer: An open-label, single-arm, phase II trial [J].

Chen, H. ;

Hu, H. ;

Fu, F. .

ANNALS OF ONCOLOGY, 2024, 35 :S787-S787

[35] Efficacy and Safety of a Therapy Combining Sintilimab and Chemotherapy With Cryoablation in the First-Line Treatment of Advanced Nonsquamous Non-Small Cell Lung Cancer: Protocol for a Phase II, Pilot, Single-Arm, Single-Center Study [J].

Gao, Zhiqiang ;

Teng, Jiajun ;

Qiao, Rong ;

Qian, Jialin ;

Pan, Feng ;

Ma, Meili ;

Lu, Jun ;

Zhang, Bo ;

Chu, Tianqing ;

Zhong, Hua .

JMIR RESEARCH PROTOCOLS, 2024, 13

[36] Evaluation of FGFR1 alterations in non-small cell lung carcinoma [J].

Wojtylak, S. ;

Sejda, A. ;

Wynes, M. W. ;

Biernat, W. ;

Rzyman, W. ;

Dziadziuszko, R. ;

Hirsch, F. R. ;

Jassem, J. .

VIRCHOWS ARCHIV, 2014, 465 :S48-S48

[37] Validation of Nanostring for FGFR1 gene expression analysis in squamous non-small cell lung cancer (sqNSCLC) tissue [J].

Rooney, C. ;

Geh, C. ;

Williams, V. ;

Cresswell, C. ;

Al-Kadhimi, K. ;

Dymond, M. ;

French, T. ;

Smith, P. D. ;

Barrett, C. ;

Harrington, E. A. ;

Kilgour, E. .

EUROPEAN JOURNAL OF CANCER, 2014, 50 :169-169

[38] Efficacy and safety of nivolumab for cytotoxic chemotherapy unfit patients with advanced non-small cell lung cancer: A phase II study [J].

Okuma, Y. ;

Kitano, S. ;

Watanabe, K. ;

Yomota, M. ;

Hosomi, Y. ;

Zenke, Y. ;

Yamamoto, N. .

ANNALS OF ONCOLOGY, 2018, 29

[39] Phase II study of liarozole in advanced non-small cell lung cancer [J].

O'Byrne, KJ ;

Han, C ;

Mitchell, K ;

Lane, D ;

Carmichael, J ;

Harris, AL ;

Talbot, DC .

EUROPEAN JOURNAL OF CANCER, 1998, 34 (09) :1463-1466

[40] A multicenter single-arm phase II study of nab-paclitaxel/carboplatin for non-small cell lung cancer patients with interstitial lung disease [J].

Usui, Y. ;

Kenmotsu, H. ;

Mori, K. ;

Ono, A. ;

Yoh, K. ;

Baba, T. ;

Fujiwara, Y. ;

Yamaguchi, O. ;

Ko, R. ;

Okamoto, H. ;

Yamamoto, N. ;

Ninomiya, T. ;

Ogura, T. ;

Kato, T. .

ANNALS OF ONCOLOGY, 2018, 29

← 1 2 3 4 5 →